Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Baosheng Pharmaceutical is a Chinese pharmaceutical company headquartered in Lanxi, Zhejiang Province, specializing in the development and manufacture of chemical drugs. Founded in 2002, the company operates high-standard GMP-certified facilities for the production of both Active Pharmaceutical Ingredients (APIs) and finished dosage forms, including tablets and capsules. Its core therapeutic focus areas include cardiovascular health, infectious diseases, and respiratory medicine. Key products in its commercial portfolio include Amlodipine Besylate for hypertension and various macrolide antibiotics such as Azithromycin and Roxithromycin. Baosheng Pharmaceutical serves a broad market, supplying essential generic medications to healthcare providers within China and exporting products to international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 保盛药业.